These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 29663062)
21. [Diagnosis of and therapy for non-muscle-invasive bladder cancer - state of the art]. Kausch von Schmeling I Aktuelle Urol; 2010 Sep; 41(5):307-15. PubMed ID: 20824576 [TBL] [Abstract][Full Text] [Related]
22. Clinical and cost effectiveness of hexaminolevulinate-guided blue-light cystoscopy: evidence review and updated expert recommendations. Witjes JA; Babjuk M; Gontero P; Jacqmin D; Karl A; Kruck S; Mariappan P; Palou Redorta J; Stenzl A; van Velthoven R; Zaak D Eur Urol; 2014 Nov; 66(5):863-71. PubMed ID: 25001887 [TBL] [Abstract][Full Text] [Related]
23. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin. Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy. Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266 [TBL] [Abstract][Full Text] [Related]
25. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer. Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396 [TBL] [Abstract][Full Text] [Related]
26. The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. Splinter TA; Scher HI; Denis L; Bukowski R; Soloway M; Vogelzang N; Klimberg I; Dalesio O; Herr H Prog Clin Biol Res; 1990; 353():219-24. PubMed ID: 2217422 [No Abstract] [Full Text] [Related]
27. [Infiltrating cancer of the bladder: can radiochemotherapy be an alternative to cystectomy?]. Chrétien Y; Mejean A; Durdux C; Dufour B; Housset M J Urol (Paris); 1996; 102(1):3-8. PubMed ID: 8763598 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186 [TBL] [Abstract][Full Text] [Related]
37. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value. Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161 [TBL] [Abstract][Full Text] [Related]
38. Muscle-invasive bladder tumour: can the bladder be preserved? Sella A BJU Int; 2008 Nov; 102(9):1053-4. PubMed ID: 18715247 [No Abstract] [Full Text] [Related]
39. Combined modality treatment with selective bladder conservation for invasive bladder cancer: long-term tolerance in the female patient. Kachnic LA; Shipley WU; Griffin PP; Zietman AL; Kaufman DS; Althausen AF; Heney NM Cancer J Sci Am; 1996; 2(2):79-84. PubMed ID: 9166504 [TBL] [Abstract][Full Text] [Related]
40. [Interdisciplinary strategies for the treatment of bladder cancer]. Bauer W; Lamche M; Schramek P Wien Med Wochenschr; 2007; 157(7-8):153-6. PubMed ID: 17492411 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]